Drug Trial Radar · NCT06527222
A Study of Ranolazine in ALS
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
72
Planned (sponsor's estimate)
Start
Apr 29, 2025
Primary completion
Jul 2028
Study completion Jul 2028
Sponsor
- Lead sponsor
- Swathy Chandrashekhar, MBBSAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- ALS Association
- First posted
- Jul 30, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.
Conditions
- Amyotrophic Lateral Sclerosis
Interventions
RanolazineDrug
500mg twice daily
RanolazineDrug
1000 mg twice daily
PlaceboDrug
Ranolazine placebo twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of Treatment-Emergent Adverse EventsTime frame: Up to 28 weeks
- Tolerability of treatment assignmentTime frame: Up to 28 weeks
- Muscle cramp frequencyTime frame: Up to 28 weeks
- Muscle cramp severityTime frame: Up to 28 weeks
- Muscle cramps impact on quality of lifeTime frame: Up to 28 weeks
- Safety Lab Cystatin CTime frame: Up to 28 weeks
- Safety Lab Estimated Glomerular Filtration Rate (eGFR)Time frame: Up to 28 weeks
- Safety Lab Alanine Transaminase (ALT)Time frame: Up to 28 weeks
- Safety Lab Aspartate Transferase (AST)Time frame: Up to 28 weeks
- Safety Lab Alkaline Phosphatase (ALP)Time frame: Up to 28 weeks
- Safety Lab Total BilirubinTime frame: Up to 28 weeks
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
University of California, San Francisco
San Francisco, California · Recruiting
Mayo Clinic Florida
Jacksonville, Florida · Recruiting
University of Kansas Medical Center
Fairway, Kansas · Recruiting
University of Kansas Medical Center: Wichita
Wichita, Kansas · Recruiting
University of Missouri Health Care
Columbia, Missouri · Recruiting
The Ohio State University
Columbus, Ohio · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.